GlassScriptPhysician profile
Jeevan B Ramakrishnan
NPI 1699972307
$11,837.80
in general payments reported to CMS, 2019-2025
20 companies · $5,223 in 2025
The $5,223 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $2,168 · 2021: $286 · 2022: $115 · 2023: $251 · 2024: $3,635 · 2025: $5,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,200 · Travel and Lodging: $2,028 · Food and Beverage: $1,787 · Consulting Fee: $60.00 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,200.00 |
| Travel and Lodging | $2,028.45 |
| Food and Beverage | $1,786.80 |
| Consulting Fee | $60.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $5,550.21 | 2019-2025 | |
| Medtronic, INC. | $2,877.27 | 2024-2025 | Straightshot, Nuvent, Propel |
| Genentech USA, INC. | $2,125.00 | 2020 | |
| Stryker Corporation | $422.50 | 2021-2025 | Scopis Ent, Audion Et Dilation System, Xpress Loprofile |
| Glaxosmithkline, LLC. | $192.03 | 2022-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $132.08 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $87.29 | 2022-2025 | Dupixent |
| Integra Lifesciences Corporation | $79.71 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Med-El Corporation | $59.82 | 2019 | |
| Neurent Medical Limited | $57.02 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Intersect Ent, INC. | $45.05 | 2019 | |
| Aerin Medical INC. | $44.58 | 2023-2024 | |
| Amgen INC. | $34.00 | 2025 | |
| Acclarent, INC | $32.98 | 2022 | |
| Hologic Sales and Service, LLC | $24.20 | 2025 | Coolseal Generator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $18.77 | 2025 | Arista |
| Ars Pharmaceuticals Operations, INC. | $15.56 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $15.03 | 2024 | Ryaltris |
| Smith+Nephew, INC. | $12.61 | 2020 | |
| C2dx, INC | $12.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeevan Ramakrishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.